Corcept Therapeutics Incorporated
CORT
$71.83
$1.371.94%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 20.55M | 30.75M | 47.21M | 35.49M | 27.76M |
| Total Depreciation and Amortization | 462.00K | 460.00K | 499.00K | 198.00K | 179.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.43M | 10.75M | -1.97M | -1.78M | 3.23M |
| Change in Net Operating Assets | -22.31M | 17.35M | 28.09M | 7.28M | -7.41M |
| Cash from Operations | 5.13M | 59.30M | 73.83M | 41.18M | 23.76M |
| Capital Expenditure | -104.00K | -121.00K | -1.64M | -416.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.07M | -64.24M | -42.40M | -59.78M | -9.01M |
| Cash from Investing | -3.17M | -64.36M | -44.04M | -60.19M | -9.01M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.46M | 2.42M | 2.27M | 3.24M | 1.69M |
| Repurchase of Common Stock | -43.26M | -6.99M | -23.36M | -5.39M | -2.23M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -39.80M | -4.56M | -21.09M | -2.15M | -543.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -37.85M | -9.62M | 8.70M | -21.16M | 14.20M |